Sana's UP421 Stem Cell Transplant Shows Promise in Type 1 Diabetes

Sana’s UP421 Stem Cell Transplant Shows Promise in Type 1 Diabetes

Sana Biotechnology’s new type of stem cell transplant islet cells shows promise for a potential treatment for type 1 diabetes. The therapy, UP421 stem cell transplant enrolled patients to avoid immune rejection and produce insulin. As Per-Ola Carlsson, M.D., study principal pnvestigator, senior physician and professor at the Clinic for Endocrinology and Diabetology at Uppsala…

The Role of Technology in Transforming Diabetes Clinical Trials

The Role of Technology in Transforming Diabetes Clinical Trials

Diabetes affects millions of people worldwide with blood conditions that change the way they live their day-to-day lives. So, scientists and doctors alike are constantly looking for ways to improve treatment options and enhance patient outcomes. Clinical trials are one of the main ways to gather information from those who actually suffer from diabetes. As well…

Genprex Announces Groundbreaking Gene Therapy to Treat Type 1 Diabetes

Genprex Announces Groundbreaking Gene Therapy to Treat Type 1 Diabetes

Previously Published on Genprex.com — Genprex, Inc. (“Genprex” or the “Company”) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that data highlighting the potential of Genprex’s gene therapy for Type 1 diabetes is being presented by its research collaborators at the University of Pittsburgh (Pitt) at the 16th International…

Vertex Buys ViaCyte and its Stem Cell-Based Diabetes Treatment for $320M

Vertex Buys ViaCyte and its Stem Cell-Based Diabetes Treatment for $320M

Previously Published on Fiercebiotech.com – Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday throws a net around ViaCyte’s stem cell-based treatment for type 1 diabetes, which has…

Bionic Pancreas Removes Math from Diabetes Process

Bionic Pancreas Removes Math from Diabetes Process

Previously Published on medwireNews – The iLet bionic pancreas closed-loop insulin delivery system provides good glucose control without the need for the user to count carbohydrates, show findings from the pivotal trial. Bionic pancreas removes math from diabetes. Instead of counting carbohydrates, users of the Beta Bionics iLet insulin-only bionic pancreas just make meal announcements with the modifier of…

Colorado Researchers Working Toward A Cure For Type 1 Diabetes
|

Colorado Researchers Working Toward A Cure For Type 1 Diabetes

Previously Published on denver.cbslocal.com – Some of the most advanced research in diabetes is being done right here in Colorado. The Barbara Davis Center is world renowned for the care and research of Type 1 diabetes. On the first floor at the center, doctors provide care to patients. In the labs on the upper floors, researchers…

A Cure for Type 1 Diabetes? It Has Worked for One Man
|

A Cure for Type 1 Diabetes? It Has Worked for One Man

Previously Published on dnyuz.com – Brian Shelton’s life was ruled by Type 1 diabetes. Could it be a cure for Type 1 Diabetes? It Has Worked for One Man. When his blood sugar plummeted, he would lose consciousness without warning. He crashed his motorcycle into a wall. He passed out in a customer’s yard while delivering mail….

Ketogenic Lifestyle is Beneficial for People with Type 1 Diabetes
|

New Study: Ketogenic Lifestyle is Beneficial for People with T1D

Previously published on Diabetestimes.co.uk – People with type 1 diabetes can benefit from a ketogenic lifestyle just as much as those without the condition. This new study was reported in the journal Endocrinology, Diabetes and Obesity. The feasibility of exercising over five days while fasting, in those with and without t1d mellitus, tested during the study. Academic, Ian Lake, analyzed…